The PKI 8135 Mobile Drug Screening is an easy-to-use drug search capture solution with a streamlined user interface. By alleviating additional steps and reducing human error in the interpretation process, organisations can save both time and money while reaping the many benefits of observed oral fluid testing with the PKI 8135 Mobile Drug Screening.
Available panel options for detection of 5 – 10 drugs, including AMP, BAR, B20, COC, MET, MTD, OPI, OXY. PCP, THC and more. The PKI 8135 Mobile Drug Screening software is for use with the oral liquid rapid test. The app automates result interpretation and reporting with an easy-to-use interface.
| Application | |
|---|---|
| QR capture and scan | |
| The built-in QR scanning function ties the specific test to the individual, eliminating user input and potential human error that can result from input. | |
| Entering donor information | |
| Using the intuitive input and selection fields, donor information such as the name, date of birth, ID, gender and reason for testing is quickly captured. | |
| Electronic consent | |
| Donor consent is captured electronically within the app using on-screen signature technology. This saves time, eliminating the need for additional paperwork or the use of alternative apps. | |
| Scan and capture | |
| Fast, accurate results without the need for manual interpretation or reporting. Drug screening results are captured via the mobile reader's smart scan technology. To capture and send, simply align the scan guides. | |
| Secure reporting | |
| Data is securely transferred between the application and the defined data centre. The scanning application also supports integration with existing systems, so real-time results can be delivered on demand. |